HCC: Management of Adverse Events with New Therapeutic Approaches

preview_player
Показать описание

In this webcast from the 'Making Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing' symposium during the 2019 Great Debates & Updates in Gastrointestinal Malignancies conference, Dr. Pashtoon Kasi discusses best practices for the management of adverse events associated with the treatment of HCC.

© 2019 Imedex, an HMP Company
  1. HMP Education
  2. Imedex
  3. CME
  4. Continuing Medical Education
  5. Education
  6. Accreditation
Рекомендации по теме
HCC: Management of 0:12:53

HCC: Management of Adverse Events with New Therapeutic Approaches

HCC Whiteboard #3: 0:03:12

HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors

Managing Adverse Events 0:12:53

Managing Adverse Events with New Therapeutic Approaches

Advanced HCC: Treatment 0:05:13

Advanced HCC: Treatment options for patients ineligible for IO - patient case video

Adverse Events Inform 0:01:33

Adverse Events Inform Treatment Decisions in HCC for Frontline Lenvatinib Versus Sorafenib

Managing Adverse Events 0:05:30

Managing Adverse Events Associated With ICI Combinations in Patients With Unresectable HCC

Optimal Management of 1:29:06

Optimal Management of HCC: Integrating Novel Therapeutic Approaches Across the Continuum of Care

Management of HCC 0:14:44

Management of HCC - Massimo Puoti, MD

The use of 0:23:22

The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)

HCC Management With 1:32:51

HCC Management With Your Multidisciplinary Team: Effective Selection and Sequencing Strategies

2nd line treatment 0:26:19

2nd line treatment in advanced HCC and when to switch

Management of Hepatocellular 0:34:29

Management of Hepatocellular Carcinoma Before Transplant

Treatment for Advanced-stage 0:01:43

Treatment for Advanced-stage HCC

Evaluating Current and 0:47:55

Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma

Impacting HCC Outcomes 0:54:56

Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management

Molecular Targeted Therapies 0:58:25

Molecular Targeted Therapies for Advanced HCC

HCC: Managing Patients 0:05:41

HCC: Managing Patients on Frontline Systemic Therapy

Hepatocellular Carcinoma: A 0:55:23

Hepatocellular Carcinoma: A Guide to Integrating Emerging Therapies into Current Treatment Paradigms

Evidence-Based Treatment Selection 1:37:24

Evidence-Based Treatment Selection and Sequencing in Advanced HCC

The Management of 0:07:35

The Management of HCC: Moving Forward

Emerging Evidence on 0:59:48

Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages

Translating Data Into 0:57:08

Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC

Drs. Goyal & 0:46:01

Drs. Goyal & Salem discuss #HCC at #SIOLongBeach - https://bit.ly/LongBeach24Y

Advanced HCC: IMbrave150 0:03:02

Advanced HCC: IMbrave150 Trial